Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Topical hypericin: a promising photodynamic therapy for early-stage cutaneous T-cell lymphoma.
Journal: Expert opinion on investigational drugs
Published: March 17, 2026
Mycosis fungoides progression following COVID-19 mRNA vaccination: A case series.
Journal: JAAD case reports
Published: March 09, 2026
Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor® (Mechlorethamine) in the Treatment of CTCL.
Journal: Oncology and therapy
Published: November 13, 2025
Mechanism of action of chlormethine gel in mycosis fungoides.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 15, 2023
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Journal: JAMA dermatology
Published: July 20, 2022
Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.
Journal: PloS one
Published: June 22, 2022
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma.
Journal: Dermatologic therapy
Published: December 01, 2021
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
Journal: Dermatology and therapy
Published: November 24, 2021
A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort Study.
Journal: Frontiers in medicine
Published: March 11, 2021
Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis.
Journal: JAAD case reports
Published: September 09, 2020
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Journal: The Lancet. Oncology
Published: March 29, 2018
Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.
Journal: American journal of clinical dermatology
Published: August 13, 2017
Last Updated: 09/26/2026